Sort by
Refine Your Search
-
Listed
-
Employer
- ;
- University of Cambridge
- University of Oxford
- King's College London
- University of Sheffield
- University of Glasgow
- Nottingham Trent University
- Cardiff University
- Durham University
- Loughborough University
- Plymouth University
- QUEENS UNIVERSITY BELFAST
- The University of Southampton
- UNIVERSITY OF SOUTHAMPTON
- University of Bath
- University of Leeds
- University of London
- University of Nottingham
- 8 more »
- « less
-
Field
-
PDRA will work in the group of Professor Tuomas Knowles in the Yusuf Hamied Department of Chemistry at the University of Cambridge. The aim of this interdisciplinary project is to develop an approach
-
Michael J. Fox Foundation. The PDRA will work in the group of Professor Tuomas Knowles in the Yusuf Hamied Department of Chemistry at the University of Cambridge. The aim of this interdisciplinary project
-
Michael J. Fox Foundation. The PDRA will work in the group of Professor Tuomas Knowles in the Yusuf Hamied Department of Chemistry at the University of Cambridge. The aim of this interdisciplinary project
-
PDRA will work in the group of Professor Tuomas Knowles in the Yusuf Hamied Department of Chemistry at the University of Cambridge. The aim of this interdisciplinary project is to develop an approach
-
Job id: 089525. Salary: £32,979 - £36,396, including London Weighting Allowance. Posted: 13 May 2024. Closing date: 30 May 2024. Business unit: Faculty of Life Sciences & Medicine. Department
-
Job id: 086988. Salary: £43,205 - £49,263 per annum, including London Weighting Allowance. Posted: 27 March 2024. Closing date: 11 April 2024. Business unit: Faculty of Life Sciences & Medicine
-
with members of the Drug Discovery Unit and academic and/or industrial collaborators to support drug discovery programmes. Today’s Science: Tomorrow’s Medicines Who we are looking for: At least a Degree
-
cells. Work at this innovation stage is entirely in vitro. The project, funded by PCUK’s Research Innovation Fund, is a first step towards delivering precision medicine to target a metabolic vulnerability
-
cells. Work at this innovation stage is entirely in vitro. The project, funded by PCUK’s Research Innovation Fund, is a first step towards delivering precision medicine to target a metabolic vulnerability
-
Department of Medicine. You will use established assays (including multi-omics approaches such as proteomics, ubiquitomics, interactomics and ABPP and to implement assays to examine the role of DUBs in CNS